Assess human papilloma virus (HPV) transcriptional activity in inverted Schneiderian papillomas (IPs).
Study Design
Case series with chart review.
Setting
Academic tertiary care center.
Subjects and Methods
Retrospective clinicopathologic review of 19 cases of IP in patients undergoing surgical excision from 1995 to 2013 at Mayo Clinic in Rochester, Minnesota. Surgical pathology archival material was histopathologically reviewed using hematoxylin and eosin–stained slides. Formalin-fixed, paraffin-embedded material from each case was evaluated for p16 expression using immunohistochemistry as well as HPV DNA and E6/E7 messenger RNA (mRNA) transcription using polymerase chain reaction (PCR) and in situ hybridization (via RNAscope technology), respectively.
Results
Eight patients were female (42%), with an average age of 53 years (range, 23-82 years). Three demonstrated malignancy, and 5 subsequently recurred. Average follow-up was 49 months (range, 0-200 months), and 1 patient died from squamous cell carcinoma arising from the IP. RNAscope detected HPV mRNA transcripts exclusively within IP in 100% of cases; however, in 11 patients (58%), less than 1% of cells exhibited transcriptional activity. Only 2 of 19 cases (11%) demonstrated mRNA activity in 50% or more cells. HPV DNA was detected in only 2 specimens by PCR.
Conclusions
This study reveals wide prevalence but limited transcriptional activity of HPV in IP. No correlation between HPV transcriptional activity and progression, recurrence, or malignant transformation was identified. These data suggest that transcription of HPV may contribute to the pathogenesis of IP, but prospective data are needed to definitively demonstrate this connection. These results also suggest that RNAscope may be more sensitive than PCR in detecting HPV activity in IP.
WardN. A mirror of the practice of medicine and surgery in the hospitals of London: London hospital. Lancet. 1854;2:480-482.
2.
BillrothT. Uber dem Bau der Schleimpolyp. Berlin, Germany: G. Reimer; 1855.
3.
KramerRSomML. True papilloma of the nasal cavity. Arch Otolaryngol. 1935;22:22-43.
4.
RingertzN. Pathology of malignant tumors arising in the nasal and paranasal sinuses and maxilla. Acta Otolaryngol. 1938;27:31-42.
5.
HyamsVJ. Papillomas of the nasal cavity and paranasal sinuses: a clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol. 1971;80:192-206.
6.
ShanmugaratnamKSobinLH. The World Health Organization histological classification of tumors of the upper respiratory tract and ear. Cancer. 1993;71:2689-2697.
7.
BuchwaldCFranzmannMBTosM. Sinonasal papillomas: a report of 82 cases in Copenhagen County, including a longitudinal epidemiological and clinical study. Laryngoscope. 1995;105:72-79.
8.
MirzaSBradleyPJAcharyaA. Sinonasal inverted papillomas: recurrence, and synchronous and metachronous malignancy. J Laryngol Otol. 2007;121:857-864.
9.
LawsonWPatelZ. The evolution of management for inverted papilloma: an analysis of 200 cases. Otolarygol Head Neck Surg. 2009;140:330-335.
10.
MelroyCTSeniorBA. Benign sinonasal neoplasms: a focus on inverting papilloma. Otolaryngol Clin North Am. 2006;39:601-617.
11.
MoonIJLeeDYSuhM-W. Cigarette smoking increases risk of recurrence for sinonasal inverted papilloma. Am J Rhinol Allergy. 2010;24:325-329.
12.
ShamCLLeeDLYvan HasseltCA. A case-control study of the risk factors associated with sinonasal inverted papilloma. Am J Rhinol Allergy. 2010;24:e37-e40.
13.
DeitmerTWienerC. Is there an occupational etiology of inverted papilloma of the nose and sinuses?Acta Otolaryngol. 1996;116:762-765.
14.
RohHJProcopGWBatraPS. Inflammation and the pathogenesis of inverted papilloma. Am J Rhinol. 2004;18:65-74.
15.
SyrjanenKSyrjanenS. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2012;123:181-192.
16.
BielamoxiczSCalcaterraTCWatsonD. Inverting papilloma of the head and neck: the UCLA update. Otolaryngol Head Neck Surg. 1993;109:71-76.
17.
PlinkertPKRuckPBaumannI. Inverted papilloma of the nose and paranasal sinuses—diagnosis, surgical procedure and studies of cytokeratin profile. Laryngorhinootologia. 1997;76:216-224.
18.
MyersENFernauJLJohnsonJT. Management of inverted papilloma. Laryngoscope. 1990;100:481-490.
19.
TufanoRPThalerERLanzaDC. Endoscopic management of sinonasal inverted papilloma. Am J Rhinol. 1999;13:423-426.
20.
TomenzoliDCastelnuovoPPagellaF. Different endoscopic surgical strategies in the management of inverted papilloma of the sinonasal tract: experience with 47 patients. Laryngoscope. 2004;114:193-200.
21.
ChiuAGJackmanAHAntunesMB. Radiographic and histologic analysis of the bone underlying inverted papillomas. Laryngoscope. 2006;116:1617-1620.
22.
LesperanceMMEsclamadoRM. Squamous cell carcinoma arising in inverted papilloma. Laryngoscope. 1995;105:178-183.
23.
BarnesL. Papillomas of the nose and paranasal sinuses. In: BarnesL, ed. Surgical Pathology of the Head and Neck. New York, NY: Marcel Dekker; 1985:408-416.
24.
BeckJCMcClatcheyKDLesperanceMM. Human papillomavirus types important in progression of inverted papilloma. Otolaryngol Head Neck Surg. 1995;113:558-563.
25.
SyrjanenKJPyrhonenSSyrjanenSM. Evidence suggesting human papillomavirus (HPV) etiology for the squamous cell papilloma of the paranasal sinus. Arch Geschwulstforsch. 1983;53:77-82.
26.
de Roda HusmanAMWalboomersJMvandenBruleAJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995;76:1057-1062.
27.
MountsPShahKV. Respiratory papillomatosis: etiological relation to genital tract papillomaviruses. Prog Med Virol. 1984;29:90-114.
28.
SyrjanenKJSyrjanenSMPyrhonenS. Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL J Otorhinolaryngol Relat Spec. 1982;44:323-334.
29.
SyrjanenSHapponenR-PVirolainenE. Detection of human papillomavirus (HPV) structural antigen and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol. 1987;104:334-341.
30.
FurutaYShinoharaTSanoK. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1991;101:79-85.
31.
LawsonWSchlechtNFBrandwein-GenslerM. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008;2:49-59.
32.
BeckJCMcClatcheyKDLesperanceMM. Presence of human papillomavirus predicts recurrence of inverted papilloma. Otolaryngol Head Neck Surg. 1995;113:49-55.
33.
BuchwaldCFranzmannM-BJacobsenGK. The presence of human papillomavirus in sinonasal papillomas, demonstrated by polymerase chain reaction with consensus primers. Hum Pathol. 1993;24:1354-1356.
34.
BuchwaldCFranzmannM-BJacobsenGK. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction. Laryngoscope. 1995;105:66-71.
35.
SarkarFHVisscherDWKintanarEB. Sinonasal Schneiderian papillomas: human papillomavirus typing by polymerase chain reaction. Mod Pathol. 1992;5:329-332.
36.
TangACGrignonDJMacRaeDL. The association of human papillomavirus with Schneiderian papillomas: a DNA in situ hybridization study. J Otolaryngol. 1994;23:292-297.
37.
ResplerDSJahnAPaterA. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988;114:23-26.
38.
SauterAMatharuRHormannK. Current advances in the basic research and clinical management of sinonasal inverted papilloma [review]. Oncol Rep. 2007;17:495-504.
39.
WeberRSShillitoeEJRobbinsKT. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988;114:23-26.
40.
KashimaHKKessisTKHrubanRH. Human papillomavirus in sinonasal papillomas and squamous cell carcinoma. Laryngoscope. 1992;102:973-976.
41.
BuchwaldCLindebergHPedersenBL. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope. 2001;111:1104-1110.
42.
McKaySPGregoireLLonardoF. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005;115:1428-1431.
43.
HwangCSYangHSHongMK. Detection of human papillomavirus (HPV) in sinonasal inverted papillomas using polymerase chain reaction (PCR). Am J Rhinol. 1998;12:363-366.
44.
HasegawaMDengZMaedaH. Human papillomavirus load and physical status in inverted papilloma and squamous cell carcinoma. Rhinology. 2012;50:87-94.
45.
JenkoKKocjanBZidarN. In inverted papillomas HPV more likely represents incidental colonization than an etiological factor. Virchows Arch. 2011;459:529-538.
46.
HarrisMOBeckJCLancasterW. The HPV 6 E6/E7 transforming genes are expressed in inverted papilloma. Otolaryngol Head Neck Surg. 1998;118:312-318.
47.
Gronhoj LarsenCGyldenloveMJensenDH. Correlation between human papillomavirus and p16 over expression in oropharyngeal tumors: a systematic review. Br J Cancer. 2014;110:1587-1594.
48.
AngKKHarrisJWheelerR. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
49.
AltavillaGStaffieriABusattoG. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol. 2009;129:1242-1249.
50.
Stasikowska-KanickaOWagrowska-DanilewiczMDanilewiczM. Effect of human papillomavirus on cell cycle-related proteins p16INK4A, p21waf1/cip1, p53 and cyclinD1 in sinonasal inverted papilloma and laryngeal carcinoma: an in situ hybridization study. Folia Histochem Cytobiol. 2011;49:34-40.
51.
ShahAAEvansMFAdamsonCS-C. HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16INK4a immunoreactivity. Head Neck Pathol. 2010;4:106-112.
52.
CheungFMFLauTWSCheungLKN. Schneiderian papillomas and carcinomas: a retrospective study with special reference to p53 and p16 tumor suppressor gene expression and association with HPV. Ear Nose Throat J. 2010;89:E5-E12.
